Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Macular Degeneration × Triamcinolone Acetonide × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 2 Lymphoma, T-Cell, Cutaneous 2 Retinal Diseases 1 Mycosis Fungoides 1 Melanoma 1 Macular Degeneration 1 Lymphomatoid Papulosis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Disease 1 Dermatitis, Contact 1 Choroid Diseases 1

Interventions

salicylhydroxamic acid 1 Triamcinolone Acetonide 1 Ranibizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00811200 2009-07-02

TORR

Leiden University Medical Center

Phase 2/3 Unknown

Uveal Melanoma, Macular Degeneration, Melanoma, Retinal Diseases, Choroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡